Aspiriant LLC Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P Small-Cap 600 Value ETF
VIOV
|
+$25.1M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$23.4M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$17.5M |
| 4 |
Dimensional National Municipal Bond ETF
DFNM
|
+$16.1M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$20.6M |
| 2 |
Vanguard Small-Cap Value ETF
VBR
|
+$10.7M |
| 3 |
Apple
AAPL
|
+$8.92M |
| 4 |
Vanguard Information Technology ETF
VGT
|
+$4.47M |
| 5 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$3.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.7% |
| 2 | Financials | 2.24% |
| 3 | Communication Services | 1.12% |
| 4 | Consumer Discretionary | 0.59% |
| 5 | Industrials | 0.57% |
Similar funds
Aspiriant LLC's Q2 2025 Portfolio in Review
As of Q2 2025, Aspiriant LLC held 317 positions worth $3.15B, up 9.2% from $2.88B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Aspiriant LLC deployed $106M of net new capital in Q2 2025, opening 29 new positions and adding to 101 existing holdings. Its largest new stake was Vanguard Short-Term Inflation-Protected Securities Index Fund: 81,710 shares worth $4.11M.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, down from 4.1% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $20.6M trimmed.
- Aspiriant LLC's largest Q2 2025 buy was Vanguard Short-Term Inflation-Protected Securities Index Fund: 81,710 shares worth $4.11M.
- Aspiriant LLC added most to Vanguard S&P Small-Cap 600 Value ETF in Q2 2025, an estimated $25.1M increase.
- Aspiriant LLC's biggest Q2 2025 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $20.6M.
- Aspiriant LLC fully exited iShares 0-3 Month Treasury Bond ETF in Q2 2025, selling an estimated $395K.
- Aspiriant LLC's ten largest holdings make up 64% of its $3.15B portfolio in Q2 2025.
- Aspiriant LLC opened 29 new positions and closed 8 in Q2 2025.
- Aspiriant LLC's portfolio value rose 9.2% quarter-over-quarter to $3.15B.
Based on Aspiriant LLC's 13F filing for Q2 2025, filed 29 Jul 2025.